Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015695 (
fatty liver
)
13,941
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
GP73
(Golph2) is a type II Golgi-localized integral membrane protein that is normally expressed in epithelial cells of many human tissues, and that is highly upregulated in liver disease. While its function is unknown, the
GP73
C-terminus contains putative protein-interaction domains. We used a gene trap approach to generate mice with a severe truncation of the
GP73
C-terminus (
GP73
(tr/tr)) in order to investigate the physiological role of this protein.
GP73
(tr/tr) mice were born at the expected rate and were fertile, but cumulative survival was significantly reduced compared to wild-type controls, particularly in females.
GP73
(tr/tr) mice developed varying degrees of renal disease, most notably focal segmental glomerulosclerosis and hyaline thrombi. In addition to renal abnormalities,
GP73
(tr/tr) mice developed marked microvesicular
hepatic steatosis
, hepatocyte nuclear membrane irregularities and intranuclear inclusions.
GP73
(tr/tr) expression in morphologically normal kidneys and livers was constitutively low, but was strikingly upregulated in the diseased kidney cortex, and was upregulated in livers in animals of advanced age. Despite the substantial morphological changes in the kidneys and liver, routine screening serum assays provided no evidence of renal or hepatic dysfunction. Consequently, the cause of the increased mortality of
GP73
(tr/tr) animals is unclear at present. Our study indicates that
GP73
is essential for normal survival, and suggests multiple roles for
GP73
in epithelial cell function in the kidney and liver.
...
PMID:Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2). 1883 Mar 87